Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do D, Schneiderman T, Ho A, Munk MR, Jaffe G, Tedford SE, Croissant CL, Walker M, Rückert R, Tedford CE. Boyer D, et al. Among authors: xavier s. Retina. 2024 Mar 1;44(3):487-497. doi: 10.1097/IAE.0000000000003980. Retina. 2024. PMID: 37972955 Free PMC article. Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial.
Boyer DS, Gonzalez VH, Kunimoto DY, Maturi RK, Roe RH, Singer MA, Xavier S, Kornfield JA, Kuppermann BD, Quiroz-Mercado H, Aubel J, Karageozian HL, Park JY, Karageozian VH, Karageozian L, Sarayba MA, Kaiser PK. Boyer DS, et al. Among authors: xavier s. Ophthalmic Surg Lasers Imaging Retina. 2021 Jun;52(6):327-335. doi: 10.3928/23258160-20210528-05. Epub 2021 Jun 1. Ophthalmic Surg Lasers Imaging Retina. 2021. PMID: 34185587 Free article. Clinical Trial.
Assessing the Impact of a Structured Capsule Endoscopy Training Program Using a New Validated Assessment Tool.
Lima Capela T, Gonçalves JC, Ferreira AI, Macedo Silva V, Macedo C, Arieira C, Xavier S, Cúrdia Gonçalves T, Boal Carvalho P, Dias de Castro F, Magalhães J, Rosa B, Moreira MJ, Cotter J. Lima Capela T, et al. Among authors: xavier s. J Gastroenterol Hepatol. 2024 Nov 25. doi: 10.1111/jgh.16823. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 39586591
A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants.
Elenge DM, Heo JS, Kim SS, Kim YK, Lee JH, Xavier S, Bahar E, Dos Santos G, Guignard A. Elenge DM, et al. Among authors: xavier s. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406060. doi: 10.1080/21645515.2024.2406060. Epub 2024 Oct 8. Hum Vaccin Immunother. 2024. PMID: 39376187 Free PMC article.
488 results